NYVCX
Price
$20.77
Change
-$0.20 (-0.95%)
Updated
Oct 16 closing price
Net Assets
6.8B
VTSAX
Price
$158.59
Change
-$1.20 (-0.75%)
Updated
Oct 16 closing price
Net Assets
2.02T
Interact to see
Advertisement

NYVCX vs VTSAX

Header iconNYVCX vs VTSAX Comparison
Open Charts NYVCX vs VTSAXBanner chart's image
Davis NY Venture C
Price$20.77
Change-$0.20 (-0.95%)
VolumeN/A
Net Assets6.8B
Vanguard Total Stock Mkt Idx Adm
Price$158.59
Change-$1.20 (-0.75%)
VolumeN/A
Net Assets2.02T
NYVCX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
NYVCX vs. VTSAX commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NYVCX is a Hold and VTSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.02T vs. NYVCX (6.8B). VTSAX pays higher dividends than NYVCX: VTSAX (1.13) vs NYVCX (0.73). NYVCX was incepted earlier than VTSAX: NYVCX (31 years) vs VTSAX (25 years). NYVCX (1.75) is less costly to investors than VTSAX (0.04). NYVCX is a more actively managed with annual turnover of: 17.00 vs. VTSAX (2.00). NYVCX has a lower initial minimum investment than VTSAX: NYVCX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 14.13 vs. NYVCX (-10.05). VTSAX return over 5 years is better than : 85.48 vs. NYVCX (-16.91).
NYVCXVTSAXNYVCX / VTSAX
Total Expense Ratio1.750.044,375%
Annual Report Gross Expense Ratio1.750.044,375%
Fund Existence31 years25 years-
Gain YTD4.67513.37835%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets6.8B2.02T0%
Annual Yield % from dividends0.731.1365%
Returns for 1 year-10.0514.13-71%
Returns for 3 years22.1178.7428%
Returns for 5 years-16.9185.48-20%
Returns for 10 years-32.95226.42-15%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDMT10.090.13
+1.31%
4D Molecular Therapeutics
NVVE0.23N/A
+0.44%
Nuvve Holding Corp
ADAG1.78-0.01
-0.56%
Adagene
CRS238.12-4.06
-1.68%
Carpenter Technology Corp
PGY27.70-2.21
-7.39%
Pagaya Technologies Ltd